Revenue ($USD) : $1,667,276,160
Revenue (foreign currencies) : 16,869,000,000 SEK kr
R&D spend : $140,150,429.00
Employees : 4,587
Fiscal year end : 04/30/23
CEO : Gustaf Salford
Also this year, Elekta entered into a joint venture with Sinopharm to increase the adoption of radiation therapy in China. –CN